Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Internal Medicine (Tokyo, Japan)
|
June 8, 2001
Malignant lymphoma of the bone associated with systemic sarcoidosis
H Kobayashi, Y Kato, M Hakamada, et al.
Mycoses
|
February 8, 2003
The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients
M Kami, Y Kishi, T Hamaki, et al.
Neurology
|
August 8, 2007
Ataxic vs painful form of paraneoplastic neuropathy
Y Oki, H Koike, M Iijima, et al.
Peptides
|
January 11, 2001
Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa
Y Muramatsu, K Fukushima, K Iino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2015
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution
C Hosing, R Bassett, B Dabaja, et al.
Blood Cancer Journal
|
August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
Y Oki, D Buglio, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2016
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
C Y Cheah, D Chihara, S Horowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
C Y Cheah, D Chihara, M Ahmed, et al.
Leukemia
|
April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
M Wang, N Fowler, N Wagner-Bartak, et al.
Current Cancer Drug Targets
|
January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
B C Potts, M X Albitar, K C Anderson, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Internal Medicine (Tokyo, Japan)
|
June 8, 2001
Malignant lymphoma of the bone associated with systemic sarcoidosis
H Kobayashi, Y Kato, M Hakamada, et al.
Mycoses
|
February 8, 2003
The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients
M Kami, Y Kishi, T Hamaki, et al.
Neurology
|
August 8, 2007
Ataxic vs painful form of paraneoplastic neuropathy
Y Oki, H Koike, M Iijima, et al.
Peptides
|
January 11, 2001
Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa
Y Muramatsu, K Fukushima, K Iino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2015
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution
C Hosing, R Bassett, B Dabaja, et al.
Blood Cancer Journal
|
August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
Y Oki, D Buglio, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2016
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
C Y Cheah, D Chihara, S Horowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
C Y Cheah, D Chihara, M Ahmed, et al.
Leukemia
|
April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
M Wang, N Fowler, N Wagner-Bartak, et al.
Current Cancer Drug Targets
|
January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
B C Potts, M X Albitar, K C Anderson, et al.
Page
of 18